Feature Channels: Vaccines

Filters close
Released: 15-Dec-2022 12:05 PM EST
Hackensack Meridian School of Medicine’s COVID Support Our Schools Initiative Assisting at Peak of Pandemic Publishes Findings
Hackensack Meridian Health

The paper concludes the COVID Support Our Schools (SOS) program helped underserved communities at a critical time - and its benefits could help with community health outreach beyond the time of a pandemic

Newswise: Shift workers have a higher risk of severe COVID-19
Released: 13-Dec-2022 2:55 PM EST
Shift workers have a higher risk of severe COVID-19
University of Bergen

Working night shifts is associated with several negative health outcomes, including an increased risk of infections.

Newswise: Attitudes around COVID-19 vaccination are linked to increased traffic risks
Released: 12-Dec-2022 6:45 PM EST
Attitudes around COVID-19 vaccination are linked to increased traffic risks
Elsevier

Reasons underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents according to a new study in The American Journal of Medicine, published by Elsevier.

6-Dec-2022 2:00 PM EST
Early engagement with affected communities helped to control mpox outbreak in Montreal
American College of Physicians (ACP)

An analysis of the first large mpox outbreak in North America found that early, sustained engagement and rapid offering of preexposure vaccination to affected communities successfully controlled the spread of the outbreak. The analysis is published in Annals of Internal Medicine.

Released: 12-Dec-2022 2:30 PM EST
Antibody discovery paves way for new therapies against group A streptococcal infections
Lund University

Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a rare form of antibody binding, that leads to an effective immune response against bacteria.

Newswise: COVID Infection, Vaccination Linked to Heart Condition
Released: 12-Dec-2022 1:25 PM EST
COVID Infection, Vaccination Linked to Heart Condition
Cedars-Sinai

Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.

Released: 12-Dec-2022 9:40 AM EST
Studies find Omicron related hospitalisations lower in severity than Delta and Pfizer-BioNTech COVID vaccine remains effective in preventing hospitalisations
University of Bristol

Adult hospitalisations from Omicron-related SARS-CoV-2 (COVID-19) were less severe than Delta and the Pfizer-BioNTech vaccine remains effective in preventing not only hospitalisation, but severe patient outcomes associated with COVID-19, two new research studies have found.

Newswise: Polarization after COVID-19: Global study published in Nature reveals that the unvaccinated face prejudice in most countries
Released: 8-Dec-2022 7:00 PM EST
Polarization after COVID-19: Global study published in Nature reveals that the unvaccinated face prejudice in most countries
Aarhus University

Across all inhabited continents of the world, people show prejudice and discriminatory attitudes towards individuals not vaccinated against COVID-19.

Released: 8-Dec-2022 1:55 PM EST
New STAT1-us quo? Novel STAT1 variants cause MSMD
Tokyo Medical and Dental University

Usually, the scariest part of childhood vaccination, for both kids and parents, is the needles. In rare cases, however, vaccines can have unexpectedly negative effects, and the secret lies in our genes.

Released: 8-Dec-2022 12:20 PM EST
Two UCI researchers named fellows by the National Academy of Inventors
University of California, Irvine

Irvine, Calif., Dec. 8, 2022 — The National Academy of Inventors has named two University of California, Irvine researchers as fellows for 2022. Philip Felgner, a pioneer in the development of lifesaving mRNA vaccines, and Payam Heydari, a prolific creator of cutting-edge microelectronics technologies, were both recognized for inventions that have made tangible impact on quality of life, economic development and the welfare of society.

Newswise: Phase 1 Trial of the First-In Human HIV Vaccine Shows Promising Results
Released: 8-Dec-2022 10:05 AM EST
Phase 1 Trial of the First-In Human HIV Vaccine Shows Promising Results
George Washington University

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science.

Released: 7-Dec-2022 4:55 PM EST
妙佑医疗国际(Mayo Clinic)专家谈儿童接种HPV疫苗的重要性
Mayo Clinic

人乳头状瘤病毒(HPV)具有100多种变异株,感染这种病毒通常会引发疣。HPV的某些变异株还可导致宫颈癌、肛门癌、阴茎癌、阴道癌、外阴癌以及咽喉癌。

7-Dec-2022 8:05 AM EST
New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants
Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.

Released: 7-Dec-2022 11:35 AM EST
National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults
Regenstrief Institute

Individuals who, despite having been vaccinated against COVID-19, develop the disease and are hospitalized are less likely to go to an intensive care unit (ICU), more likely to have a shorter hospital stay, and less likely to die in the hospital than individuals hospitalized for COVID who were never vaccinated, according to a national study from the Centers for Disease Control and Prevention’s VISION Network.

Newswise:Video Embedded lji-scientists-confirm-smallpox-vaccine-also-teaches-t-cells-to-fight-mpox
VIDEO
Released: 6-Dec-2022 8:30 PM EST
LJI scientists confirm smallpox vaccine also teaches T cells to fight mpox
La Jolla Institute for Immunology

"Vaccines such as JYNNEOS should be able to induce T cells that also recognize mpox and can provide protection from severe disease."

   
Released: 5-Dec-2022 4:05 PM EST
We ain't misbehavin' here. The latest news in Behavioral Science on Newswise
Newswise

Here are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.

       
Released: 5-Dec-2022 11:10 AM EST
Dramatic change in proportion of the Canadian population with SARS-CoV-2 antibody over the first 2.5 years of pandemic
Canadian Medical Association Journal

By August 2022, most children and adults younger than 60 years in Canada had been exposed to SARS-CoV-2 through a combination of vaccination and infection, according to a large study looking at blood antibodies published in CMAJ (Canadian Medical Association Journal)

2-Dec-2022 5:50 PM EST
Vaccine hesitancy predicts future COVID-19 vaccine side effects
Bar-Ilan University

The precise relationship between vaccine hesitancy and COVID-19 vaccination side effects has not previously been explored in vaccinated persons. A fundamental question arises in regard to the directionality of this vaccine hesitancy-vaccine side effect link, namely which variable predicts which. One possibility is that side effects from an earlier dose predict one’s vaccine hesitancy towards a later dose. Alternatively, one’s psychological negativity (hesitancy) towards an earlier dose could predict subsequent side effects from a later vaccination dose. The latter direction reflects a Nocebo effect, i.e., side effects driven by psychological factors rather than by an active treatment component. Results showed only the latter direction to be true. Namely, only earlier vaccine hesitancy towards the second COVID-19 dose predicted subsequent nocebo side-effects following the booster vaccination. To put this in perspective up to 16% of one’s vaccine side effects were explained by earlier va

Released: 1-Dec-2022 7:55 PM EST
Immune T cell defence is coping with COVID-19 variants of concern – for now
University of Birmingham

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.



close
2.69533